Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bristol-Myers and Vedanta to study combination therapy for cancer

pharmaceutical-technologyDecember 12, 2018

Tag: Bristol-Myers , Vedanta , Cancer , combination therapy

PharmaSources Customer Service